Literature DB >> 22241650

Treatment of infantile hemangiomas with the 595-nm pulsed dye laser using different pulse widths in an Asian population.

Yong-Kwang Tay1, Siew-Kiang Tan.   

Abstract

INTRODUCTION: The pulsed dye laser (PDL) using varying fluences and pulse durations have been used to treat hemangiomas. This study aims to examine the efficacy and safety of the 595-nm PDL for the treatment of infantile hemangiomas using short (1.5-3 milliseconds) versus long (10 milliseconds) pulse durations and high fluences.
MATERIALS AND METHODS: This is a retrospective study of patients with hemangiomas (n = 23) treated with the 595-nm PDL from 2003 to 2007. The parameters used for the short pulse duration group (n = 15) were 7-mm spot size, fluence 10-13.5 J/cm(2) and dynamic cooling device (DCD) spray duration of 50 milliseconds and delay of 30 milliseconds. For the long pulse duration group (n = 8), parameters were 7-mm spot size, fluence 10.5-14.5 J/cm(2) and DCD spray duration of 40 milliseconds and delay of 20 milliseconds.
RESULTS: The number of treatments required to achieve complete or near complete resolution of the hemangioma ranged from 3 to 14 for the short pulse duration group (mean: 8) and for the long pulse duration group, 4-14 treatments (mean: 9). For both groups, more treatments were needed to achieve clearance of mixed hemangiomas (n = 13) compared to superficial hemangiomas (n = 10) (on average, 4-5 treatments more). Erythema, edema, and purpura lasted for about a week in the short pulse duration group but only 2 days in the long pulse duration group. There was no ulceration or hypertrophic scarring noted in both groups.
CONCLUSION: Both short and long pulse durations using moderately high fluences are equally effective in the treatment of infantile hemangiomas. Shorter pulse durations had a slightly higher incidence of side effects compared to longer pulse duration in our patients with darker phototypes. Hemangiomas are tumors with relatively large diameter blood vessels and this provides the basis for the use of longer pulse durations.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22241650     DOI: 10.1002/lsm.21159

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  6 in total

1.  Superficial hemangioma is better treated by topical 5-aminolevulinic followed by 595-nm pulsed dye laser therapy rather than 595-nm laser therapy alone.

Authors:  Ming Zeng; Songke Shen; Wei Chen; Chunjun Yang; ShengXiu Liu
Journal:  Lasers Med Sci       Date:  2017-08-16       Impact factor: 3.161

2.  The sensitivity in the IR spectrum of the intact and pathological tissues by laser biophotometry.

Authors:  Cristian Ravariu; Ala Bondarciuc
Journal:  Lasers Med Sci       Date:  2013-06-08       Impact factor: 3.161

3.  One Possible Mechanism of Pulsed Dye Laser Treatment on Infantile Hemangioma: Induction of Endothelial Apoptosis and Serum vascular endothelial growth factor (VEGF) Level Changes.

Authors:  Yongqian Cao; Fagang Wang; Qingwei Jia; Rongjian Xu; Wei Dang; Qing Chen; Li Lin; Yibing Wang
Journal:  J Lasers Med Sci       Date:  2014

4.  Efficacy Evaluation of 755-nm Long-Pulse Alexandrite Laser Combined with 0.5% Timolol Maleate Eye Drops in the Treatment of Thicker Infantile Hemangioma.

Authors:  Jianming Wu; Fangyan Zhou; Yu Gao
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-11-09

5.  Pulsed dye laser and topical timolol gel versus pulse dye laser in treatment of infantile hemangioma: A double-blind randomized controlled trial.

Authors:  Ali Asilian; Fatemeh Mokhtari; Atefeh Sadat Kamali; Bahareh Abtahi-Naeini; Mohammad Ali Nilforoushzadeh; Shayan Mostafaie
Journal:  Adv Biomed Res       Date:  2015-11-30

Review 6.  Proanthocyanidins as a Potential Novel Way for the Treatment of Hemangioma.

Authors:  Ran Tang; Dehai Xian; Jixiang Xu; Huiling Peng; Shihong Pan; Jianqiao Zhong
Journal:  Biomed Res Int       Date:  2021-01-02       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.